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Abstract
A key promise of AI applications in healthcare is in increasing access to quality
medical care in under-served populations and emerging markets. However, deep
learning models are often only trained on data from advantaged populations that
have the infrastructure and resources required for large-scale data collection. In this
paper, we aim to empirically investigate the potential impact of such biases on breast
cancer detection in mammograms. We specifically explore how a deep learning
algorithm trained on screening mammograms from the US and UK generalizes
to mammograms collected at a hospital in China, where screening is not widely
implemented. For the evaluation, we use a top-scoring model developed for the
Digital Mammography DREAM Challenge. Despite the change in institution and
population composition, we find that the model generalizes well, exhibiting similar
performance to that achieved in the DREAM Challenge, even when controlling for
tumor size. We also illustrate a simple but effective method for filtering predictions
based on model variance, which can be particularly useful for deployment in new
settings. While there are many components in developing a clinically effective
system, these results represent a promising step towards increasing access to life-
saving screening mammography in populations where screening rates are currently
low.
Introduction
In the United States, screening mammography has been attributed as a major factor in averting hun-
dreds of thousands of breast cancer deaths [1]. The prevalence of screening mammography, however,
is often dramatically lower in many emerging markets, including China [2, 3]. Inadequate funding and
a shortage of qualified readers are contributing factors to China’s low screening rates [2]. AI could
increase access to screening via its scalability and potential to provide low cost and accurate initial
interpretation for many mammograms. For instance, a triage-style clinical implementation could
significantly reduce overall workload for clinicians, while maintaining high diagnostic accuracy [4].
In this scenario, the majority of women with mammograms confidently interpreted as normal by
the AI software could be recommended for subsequent routine mammography the following year,
where the remainder of women would be referred for further clinician interpretation and work-up,
thus lightening the clinical load.
There has indeed been much recent work illustrating the promise of AI in mammogram interpreta-
tion [5, 6, 7, 8, 9, 10]. However, it is often unclear how well these methods generalize, as they are
usually evaluated on data drawn from the same distribution as the training set, i.e. similar populations
and/or hospitals [11]. With goals of deploying such solutions in different markets, their performance
on the intended population must be verified, especially as it is often infeasible to collect enough
training data from these populations. Generalization is certainly not guaranteed given the high
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sensitivity of deep learning models to input statistics [12, 13]. For mammography in particular, there
are known (and possibly unknown) biological differences in mammograms between US and Chinese
populations, such as a greater proportion of dense breasts in the Chinese population [14], which can
make mammogram interpretation more difficult. Here, we tested how well a top-performing model
from Digital Mammography DREAM Challenge [15], a large-scale data science competition that
concluded in early 2018, generalizes to a collection of mammograms acquired at a Chinese hospital.
Additionally, we explore the use of an empirical measure of prediction uncertainty, quantified as the
variance over models and data augmentations in an ensemble, as a prediction deferment strategy,
which could be useful in deployment in novel settings.
Methods
Model Architecture and Training Procedure
The tested algorithm was designed for the Digital Mammography DREAM Challenge [15], a unique
competition where neither the training data nor the testing data (all from the United States) were
available for download. Instead, competitors made submissions using Docker containers, which would
have access to the data when run on the DREAM servers. Another challenge was that only breast-level
labels were available for training; specifically there were only binary cancer/no-cancer labels for
each patient and laterality (left/right), with no tumor localization information. Given the “needle-
in-a-haystack” nature of detecting cancer in mammograms, training standard image classification
approaches using only image-level labels quickly leads to overfitting. To more effectively train
on the DREAM data, we developed a two-stage training scheme, which first consisted of training
convolutional neural networks (CNNs) on cropped mammogram patches using publicly-available,
strongly-labeled data; and then using these CNNs to initialize a fully-convolutional network that
outputs a classification given a full-scale image [6] (Figure 1). By first training to predict the
presence of a cancerous lesion in a 256x256px mammogram patch, the CNN is better initialized for
end-to-end training on full-scale images, for which we resize to have a height of 1750px. We used
the DDSM [16] and Optimam [17] datasets for patch pre-training. DDSM consists of 2,602 scanned
film mammography studies from the US (35% cancers, 33% benigns, and 31% normals), while the
version of Optimam used here contains 13,973 digital mammography studies from the UK (26%
cancers, 2.5% benigns, and 72% normals).
For the backbone of our network, we used MobileNet [18], as its memory efficient structure enabled
full-image training on the GPUs available in the DREAM Challenge. Converting the patch model to
the full-image model consisted of using a global average pooling layer on top of the final convolutional
feature map layer, followed by a single fully-connected layer. The overall training procedure consisted
of 1) patch-level training on DDSM & Optimam, 2) image-level training on DDSM & Optimam,
and 3) image-level training on the DREAM dataset. Due to the class imbalance between cancer/no-
cancer images, we sampled equally from each class during all three training stages. The final model
consisted of an ensemble of three models trained in a similar fashion. Each model averages scores
from vertically mirrored orientations of the same image, and an image-level score is computed
as a weighted average between the three models. A study-level score is computed by averaging
image-level scores across views (cranio-caudal (CC) and mediolateral oblique (MLO)), before taking
the max score over lateralities (left and right). This submission achieved an area under the receiver
operating characteristic curve (AUROC) of 0.90, which was the highest submission score over all
phases of the Challenge.
Evaluation on Data from a Chinese Hospital
To test the generalization of the DREAM model, an evaluation dataset consisting of 2533 cases (533
pathologically-proven cancers, 1000 pathologically-proven benigns, and 1000 normals) was gathered
from an urban hospital in China. Each case consisted of the four standard mammographic views (CC
and MLO of both the left and right breast). The data was retrospectively collected from a contiguous
period of time from 2012-2017. Given low screening rates, the data came from diagnostic exams, i.e.
exams where the patient presented with symptoms, so the distribution of tumor sizes from the cancer
cases contained more large tumors (64% larger than 2cm) than would be expected in a typical United
States screening population [19]. Thus, we report results on the original data distribution, as well
as a tumor-size normalized performance, using bootstrap re-sampling simulations to approximately
2
Figure 1: Illustration of the two-stage approach used to develop our top-scoring Dream Challenge
model, which was trained on US and UK data, and evaluated on data from a Chinese hospital in this
work.
Figure 2: Receiver operating characteristic (ROC) curve of the DREAM model evaluated on the
tested Chinese dataset containing 2533 total cases.
match the tumor size distribution observed in US screening data [20]. All results were calculated by
running the containerized DREAM submission locally at the Chinese hospital with no transfer of
imaging data. As a measure of model uncertainty for a given image [21], we quantify the variance in
prediction scores across the three models and two vertical orientations (6 total scores). An uncertainty
score per breast is then calculated as the average in variances across views for that breast.
Results
On the original Chinese dataset, the DREAM model achieved 0.93± 0.01 AUROC for breast-level
predictions, as illustrated in Figure 2. In terms of a simulated triage scenario, these results would
translate to interpreting 60% of normal mammograms as such, while operating at 95% sensitivity.
When controlling for tumor size using 1000 bootstrap simulations to match US screening statistics,
the model achieved 0.90 ± 0.03 AUROC. This level of performance is thus consistent with the
0.90 AUROC results from the DREAM Challenge. Estimating breast density using an open source
tool [22], we observe an AUROC of 0.914 on dense breasts and 0.946 non-dense breasts, respectively.
The difference of 0.03 AUROC is also consistent with results from the DREAM Challenge. Finally,
as an additional performance measure, the model achieves an AUROC of 0.94 when only considering
normal and malignant cases (i.e., excluding the benigns).
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Additionally, we find that the variance between prediction scores in the model ensemble (3 models
across 2 image orientations) provides a practical empirical method of filtering model predictions.
The cases that exhibit high prediction variance seem to also be the cases that the algorithm tends to
misclassify, as excluding cases based on this metric tends to increase AUROC (Fig. 3). In analyzing
the proportion of each type of case (normal, benign, malignant) that is filtered as the percentage of
filtered cases increases, we observe that there is a slight trend towards initially excluding benign cases
(Fig. 3), though the relative proportion of each type remains relatively consistent up to excluding
~40% of cases.
Figure 3: (Left) AUROC by percentage of samples filtered based on the uncertainty criteria. We
compute and rank order the uncertainty criteria for each sample in the evaluation set. The x-axis
is the percentage of data removed, starting with highest variance samples, while the y-axis reports
the AUROC achieved on that subset of data. (Right) Relative proportion of malignant, benign, and
normal cases in the data as the percent removed based on ranked variance increases. The plot infers
that benign lesions generally show highest model variance, followed by normal and malignant lesions.
Discussion
While the development of better performing models will always be a goal in AI research, validating
that existing algorithms can perform equally well in new clinical settings is crucial to ensure that AI
can effectively serve broad populations. In this study, we demonstrated that a model that was trained
on data from the US and UK and achieved state-of-the-art performance on the Digital Mammography
DREAM Challenge generalizes well to data collected at an urban Chinese hospital. While the
testing data used in this study largely came from diagnostic exams, as screening rates are relatively
low in China, the performance was comparable to the United States results even when sampling
to approximately match tumor size statistics found in the US. We also note that, while the data
was diagnostic, each case consisted of the four standard mammographic (screening) views. The
multi-faceted data used to train our model, consisting of film and digital mammograms and three
datasets in total, could be a factor in the demonstrated generalizability. It could also be the case
that the variation in mammographic image statistics within a demographic population tends to be
larger than the variability between demographics. Since the evaluation performed here is without
additional training, it is also reasonable to expect performance improvements in a setting where new
data is available for fine-tuning the model. In addition to demonstrating generalizability, we propose
a method for the deferring of model predictions via an empirical uncertainty measure formulated as
the variance of scores between models in an ensemble. This can be especially useful in novel settings,
where cases exhibiting a level of uncertainty above a threshold can be reserved solely for physician
interpretation. Overall, while further work is needed, these results are a promising initial step towards
the deployment of a mammography AI system to a population where screening mammography is
currently limited.
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